End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
179,500 KRW | -0.11% | +4.97% | -10.92% |
Apr. 24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
Apr. 17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.92% | 27.04B | |
+4.09% | 43.84B | |
+9.45% | 41.68B | |
+45.89% | 41.25B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+1.28% | 12.29B | |
+29.70% | 12.29B | |
+7.78% | 11.15B | |
-17.68% | 9.98B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion's COVID-19 Treatment Drug Demonstrates Safety in Clinical Trial